
Atara’s Balancing Act: Innovation On A Fiscal Tightrope (NASDAQ:ATRA)
At a Glance Atara Biotherapeutics (NASDAQ:ATRA), perched on the cutting edge with tab-cel and ATA188, encounters a pivotal phase, balancing its clinical ingenuity against